GO:0008757 S-adenosylmethionine-dependent methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008757 describes the molecular function of transferring a methyl group from S-adenosyl-L-methionine (SAM) to a substrate, a central reaction in epigenetic regulation, metabolism, and natural product biosynthesis.
• SAM-dependent methyltransferases share a conserved Rossmann-like fold that binds SAM and positions the methyl group for transfer to diverse substrates including DNA, RNA, proteins, and small molecules.
• These enzymes are essential for viral replication, as shown by SARS-CoV-2 methyltransferases that cap viral RNA and are inhibited by compounds like DZNep.
• Dysregulation of SAM-dependent methylation is linked to cancer, neurological disorders, and arsenic toxicity, making these enzymes attractive therapeutic targets.
• CRISPR-based knockout, point mutation, and knock-in models enable precise dissection of methyltransferase gene function in disease and development.
• EDITGENE provides end-to-end services for generating and screening SAM-dependent methyltransferase cell models, accelerating target validation and drug discovery.
Description
S-adenosylmethionine-dependent methyltransferase activity (GO:0008757) is a fundamental molecular function that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (SAM) to a wide range of substrates, including DNA, RNA, proteins, lipids, and small molecules. This activity is essential for epigenetic regulation, cellular metabolism, and the biosynthesis of numerous secondary metabolites. Researchers study this term to understand how methylation controls gene expression, viral replication, and disease progression. The reaction is highly conserved across all domains of life, with SAM serving as the universal methyl donor. Because methylation is reversible and dynamically regulated, SAM-dependent methyltransferases are promising targets for therapeutic intervention in cancer, infectious diseases, and metabolic disorders. This article provides a comprehensive overview of the mechanism, key genes, disease associations, and research methods for studying GO:0008757, with a focus on CRISPR-based models and EDITGENE services.
S-adenosylmethionine-dependent methyltransferase activity At A Glance
| GO ID | GO:0008757 |
|---|---|
| GO term | S-adenosylmethionine-dependent methyltransferase activity |
| Ontology | molecular_function |
| Synonym | SAM-dependent methyltransferase activity; S-adenosyl methionine-dependent methyltransferase activity |
| Definition | Catalysis of the transfer of a methyl group from S-adenosyl-L-methionine to a substrate. |
| Major function | Methyl group transfer to DNA, RNA, proteins, and small molecules |
| Cofactor | S-adenosyl-L-methionine (SAM) as methyl donor |
| Structural fold | Rossmann-like SAM-binding fold |
| Related diseases | Cancer, viral infections, neurological disorders, arsenic toxicity |
What Is GO:0008757?
GO:0008757, S-adenosylmethionine-dependent methyltransferase activity, is defined by the Gene Ontology as the catalysis of methyl group transfer from S-adenosyl-L-methionine to a substrate [QuickGO]. In other words, it is the enzymatic activity that uses SAM as a methyl donor to modify target molecules, a process critical for epigenetic marking, detoxification, and biosynthesis.
Why Is S-adenosylmethionine-dependent methyltransferase activity Important in Cell Biology?
S-adenosylmethionine-dependent methyltransferase activity is central to epigenetic regulation, cellular metabolism, and host-pathogen interactions. It controls gene expression through DNA and histone methylation, modulates RNA stability and translation via RNA methylation, and is exploited by viruses such as SARS-CoV-2 for RNA cap formation. Inhibitors of these enzymes, like DZNep, show antiviral activity with a low tendency to select for drug-resistant variants, highlighting their therapeutic potential. Moreover, environmental toxins such as arsenic disrupt SAM-dependent methylation, leading to oxidative stress and disease. Understanding this activity is therefore critical for developing targeted therapies and for interpreting disease mechanisms.
• Regulates gene expression through DNA and histone methylation, impacting development and disease.
• Essential for viral RNA cap formation and replication, as shown for SARS-CoV-2.
• Involved in detoxification pathways, including arsenic metabolism in plants and humans.
• Provides targets for anticancer and antiviral drugs, such as DZNep.
• Plays a role in neurotransmitter synthesis and neurological function.
• Contributes to antibiotic resistance and natural product biosynthesis in microbes.
• Dysregulation is linked to metabolic disorders and cancer.
• Enables epigenetic reprogramming in stem cells and development.
• Serves as a biomarker for environmental exposure and disease progression.
• Facilitates high-throughput screening for methyltransferase inhibitors.
What Happens During S-adenosylmethionine-dependent methyltransferase activity?
SAM Binding and Substrate Recognition
In simple terms: The enzyme grabs SAM and holds it next to the target molecule.
The methyltransferase binds S-adenosyl-L-methionine (SAM) in a conserved Rossmann-like fold, positioning the reactive methyl group for transfer. Substrate recognition varies widely, from DNA bases to protein lysine residues, and is mediated by specific binding pockets.
Methyl Group Transfer
In simple terms: The methyl group is handed over to the substrate.
A nucleophilic attack by the substrate on the SAM methyl group leads to methyl transfer, producing S-adenosylhomocysteine (SAH) as a byproduct. This step is often rate-limiting and can be regulated by product inhibition.
Product Release and Recycling
In simple terms: The methylated product is released and SAH is recycled.
After methyl transfer, the methylated substrate dissociates, and SAH is hydrolyzed to homocysteine and adenosine, allowing SAM regeneration. This cycle is critical for maintaining cellular methylation potential.
Regulation by SAM/SAH Ratio
In simple terms: The balance of SAM and SAH controls enzyme activity.
The intracellular SAM/SAH ratio, often called the methylation index, regulates methyltransferase activity. Changes in this ratio due to diet or disease can alter epigenetic marks and gene expression.
Key Genes Involved in GO:0008757 S-adenosylmethionine-dependent methyltransferase activity
The following genes encode enzymes with SAM-dependent methyltransferase activity, representing diverse substrate specificities and biological functions.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DNMT1 | DNA methylation maintenance | Epigenetic silencing in cancer |
| DNMT3A | De novo DNA methylation | Developmental disorders and leukemia |
| DNMT3B | De novo DNA methylation | ICF syndrome and cancer |
| EHMT2 | Histone H3K9 methylation | Transcriptional repression in cancer |
| SUV39H1 | Histone H3K9 methylation | Heterochromatin formation |
| PRMT1 | Protein arginine methylation | RNA processing and signaling |
| PRMT5 | Protein arginine methylation | Splicing regulation and cancer |
| METTL3 | RNA m6A methylation | mRNA stability and translation |
| METTL14 | RNA m6A methylation | Embryonic development |
| NSUN2 | RNA m5C methylation | tRNA stability and cancer |
| TRMT112 | tRNA methylation | Protein translation |
| COMT | Catecholamine methylation | Neurotransmitter degradation |
| GNMT | Glycine methylation | Liver detoxification |
| AS3MT | Arsenic methylation | Detoxification of arsenic |
| NSP14 | Viral RNA cap methylation | SARS-CoV-2 replication |
| NSP16 | Viral RNA cap methylation | SARS-CoV-2 immune evasion |
| DZNep | Inhibitor of SAM-dependent methyltransferases | Antiviral and anticancer studies |
How Is S-adenosylmethionine-dependent methyltransferase activity Regulated?
SAM-dependent methyltransferase activity is regulated at multiple levels. The availability of SAM, determined by dietary methionine and folate, directly influences enzyme activity. Product inhibition by SAH and the SAM/SAH ratio modulate catalytic rates. Post-translational modifications and protein-protein interactions also control methyltransferase recruitment and activity. In viral infections, viral methyltransferases are expressed at specific stages to cap viral RNA and evade host immunity. Environmental factors such as arsenic exposure can alter SAM-dependent methylation, leading to toxicity.
S-adenosylmethionine-dependent methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DNMT1 | Cancer, epigenetic silencing | Knockout in cancer cell lines |
| NSP14 | SARS-CoV-2 replication | Overexpression in HEK293 cells |
| COMT | Schizophrenia, Parkinson's disease | Point mutation knock-in mice |
| AS3MT | Arsenic toxicity | Knockout in hepatocytes |
| METTL3 | Acute myeloid leukemia | Knockout in leukemia cells |
Cancer
Altered DNA and histone methylation patterns are hallmarks of cancer. Overexpression of DNMTs and PRMTs leads to silencing of tumor suppressor genes and activation of oncogenes. Inhibitors like DZNep show promise in blocking cancer cell proliferation by disrupting methylation.
Viral Infections
SARS-CoV-2 encodes SAM-dependent methyltransferases (NSP14 and NSP16) that cap viral RNA, enhancing translation and immune evasion. DZNep inhibits these enzymes, reducing viral replication with a low tendency to select for drug-resistant variants.
Neurological Disorders
COMT, a SAM-dependent methyltransferase, degrades dopamine and is implicated in schizophrenia and Parkinson's disease. Polymorphisms in COMT affect enzyme activity and drug response.
Arsenic Toxicity
AS3MT methylates arsenic for detoxification. Chronic exposure to arsenic disrupts SAM-dependent methylation, leading to oxidative stress and increased disease risk.
From S-adenosylmethionine-dependent methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DNMT1 affect tumor growth? | DNMT1 knockout cancer cell line |
| Does a COMT polymorphism alter dopamine levels? | COMT point mutation knock-in mice |
| Can NSP14 methyltransferase activity be inhibited? | NSP14 overexpression in HEK293 cells |
| What is the role of METTL3 in mRNA stability? | METTL3 knockout stem cells |
| Does AS3MT protect against arsenic toxicity? | AS3MT knockout hepatocytes |
| Can DZNep inhibit viral methyltransferases? | Overexpression of viral NSP14/NSP16 |
How to Study the S-adenosylmethionine-dependent methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive SAM assay | Methyltransferase activity | Enzyme kinetics |
| LC-MS/MS | Methylated products and SAM/SAH | Metabolic profiling |
| CRISPR knockout screen | Gene essentiality | Target discovery |
| RNA-seq | Transcriptional changes | Epigenetic regulation |
| ChIP-seq | Histone methylation | Chromatin mapping |
| Cryo-EM | Protein structure | Mechanistic studies |
| DZNep treatment | Inhibition of methylation | Antiviral/anticancer |
Methyltransferase Activity Assays
In vitro assays using radioactive or fluorescent SAM measure methyl transfer to substrates, enabling kinetic characterization and inhibitor screening.
Mass Spectrometry
LC-MS/MS quantifies methylated substrates and SAM/SAH ratios, providing insights into cellular methylation status.
CRISPR Screening
Genome-wide CRISPR knockout libraries identify genes required for methyltransferase activity and resistance to inhibitors.
Structural Biology
X-ray crystallography and cryo-EM reveal the SAM-binding fold and substrate recognition mechanisms.
How CRISPR Can Be Used to Study GO:0008757 S-adenosylmethionine-dependent methyltransferase activity
Knockout
CRISPR knockout of SAM-dependent methyltransferase genes (e.g., DNMT1, METTL3) ablates enzyme activity, revealing loss-of-function phenotypes in cancer, development, and viral infection.
Point Mutation
Introducing catalytic-dead or patient-derived point mutations (e.g., in COMT or DNMT3A) via CRISPR base editing allows precise dissection of enzyme activity versus scaffolding functions.
Knock-in
Knock-in of tagged or reporter alleles (e.g., GFP-DNMT1) enables live-cell imaging and proteomic analysis of methyltransferase complexes.
Overexpression
CRISPR activation or lentiviral overexpression of viral methyltransferases (e.g., NSP14) facilitates antiviral drug screening and mechanistic studies.
How EDITGENE Supports S-adenosylmethionine-dependent methyltransferase activity Research
Researchers studying S-adenosylmethionine-dependent methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as cancer cell proliferation or viral replication. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling functional validation and drug discovery.
Contact EDITGENE today to design your custom CRISPR model for S-adenosylmethionine-dependent methyltransferase activity research.
Frequently Asked Questions About S-adenosylmethionine-dependent methyltransferase activity
What is S-adenosylmethionine-dependent methyltransferase activity?
It is the enzymatic activity (GO:0008757) that transfers a methyl group from SAM to a substrate, a key reaction in epigenetics and metabolism.
What genes are involved in S-adenosylmethionine-dependent methyltransferase activity?
Genes include DNMT1, DNMT3A, EHMT2, PRMT1, METTL3, and viral NSP14, among others.
How is SAM-dependent methyltransferase activity regulated?
It is regulated by SAM availability, the SAM/SAH ratio, post-translational modifications, and protein interactions.
What diseases are associated with SAM-dependent methyltransferases?
Cancer, viral infections, neurological disorders, and arsenic toxicity.
How can I study SAM-dependent methyltransferase activity in the lab?
Use activity assays, mass spectrometry, CRISPR knockout models, and structural biology.
What is the role of SAM in methylation?
SAM is the universal methyl donor, providing the methyl group for transfer to substrates.
Can CRISPR be used to study SAM-dependent methyltransferases?
Yes, CRISPR knockout, point mutation, and knock-in models enable precise functional studies.
What is DZNep and how does it relate to SAM-dependent methyltransferases?
DZNep is an inhibitor of SAM-dependent methyltransferases with antiviral and anticancer activity.
What is the SAM-binding fold?
It is a conserved Rossmann-like structural motif that binds SAM in methyltransferases.
How does arsenic affect SAM-dependent methylation?
Arsenic disrupts SAM-dependent methylation, leading to oxidative stress and toxicity.
Conclusion
S-adenosylmethionine-dependent methyltransferase activity (GO:0008757) is a cornerstone of epigenetic regulation, metabolism, and host-pathogen interactions. Its dysregulation contributes to cancer, viral infections, and neurological disorders, making it a prime target for therapeutic intervention. Advances in CRISPR-based models and screening technologies are accelerating the discovery of specific inhibitors and biomarkers. EDITGENE offers comprehensive services to support research on this critical enzyme family, from knockout cell lines to bioinformatics analysis.
References
- 1. Kozarich JW. 1988. S-adenosylmethionine-dependent enzyme activation.. Biofactors 1(2):123-8 PMID: 3076439
- 2. Kumar R et al.. 2022. S-adenosylmethionine-dependent methyltransferase inhibitor DZNep blocks transcription and translation of SARS-CoV-2 genome with a low tendency to select for drug-resistant viral variants.. Antiviral Res 197:105232 PMID: 34968527
- 3. Mushegian A. 2022. Methyltransferases of Riboviria.. Biomolecules 12(9) PMID: 36139088
- 4. Masum MHU et al.. 2023. In Silico Functional Characterization of a Hypothetical Protein From Pasteurella Multocida Reveals a Novel S-Adenosylmethionine-Dependent Methyltransferase Activity.. Bioinform Biol Insights 17:11779322231184024 PMID: 37424709
- 5. Wooderchak WL et al.. 2008. Assays for S-adenosylmethionine (AdoMet/SAM)-dependent methyltransferases.. Curr Protoc Toxicol Chapter 4:Unit4.26 PMID: 23045008
- 6. Martin JL et al.. 2002. SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold.. Curr Opin Struct Biol 12(6):783-93 PMID: 12504684
- 7. Mark Mondol S et al.. 2022. In Silico Identification and Characterization of a Hypothetical Protein From Rhodobacter capsulatus Revealing S-Adenosylmethionine-Dependent Methyltransferase Activity.. Bioinform Biol Insights 16:11779322221094236 PMID: 35478993
- 8. Ranjan R et al.. 2021. Chlorella sp. modulates the glutathione mediated detoxification and S-adenosylmethionine dependent methyltransferase to counter arsenic toxicity in Oryza sativa L.. Ecotoxicol Environ Saf 208:111418 PMID: 33045435
